{
  "id": "7e40c1da4da1ef00",
  "title": "STAT+: Pharmalittle: We\u2019re reading about FDA\u2019s Prasad defending his plans, a Merck setback in Germany, and more",
  "description": "In today's Pharmalittle roundup, we're reading about FDA's Prasad defending his plans, a Merck setback in Germany, and more.",
  "content": "In today's Pharmalittle roundup, we're reading about FDA's Prasad defending his plans, a Merck setback in Germany, and more.",
  "source": "STAT",
  "source_url": "https://www.statnews.com/pharmalot/2025/12/05/fda-prasad-mark-cuban-generics-keytruda-pharmalittle-newsletter/?utm_campaign=rss",
  "published_at": "2025-12-05T14:22:11+00:00",
  "fetched_at": "2025-12-06T18:33:06.472112+00:00",
  "category": "health_biotech",
  "subcategory": null,
  "keywords": [
    "fda"
  ],
  "location": null,
  "raw_data": {
    "title": "STAT+: Pharmalittle: We\u2019re reading about FDA\u2019s Prasad defending his plans, a Merck setback in Germany, and more",
    "description": "In today's Pharmalittle roundup, we're reading about FDA's Prasad defending his plans, a Merck setback in Germany, and more.",
    "url": "https://www.statnews.com/pharmalot/2025/12/05/fda-prasad-mark-cuban-generics-keytruda-pharmalittle-newsletter/?utm_campaign=rss",
    "published": "2025-12-05T14:22:11+00:00",
    "source": "STAT"
  }
}